OLD National Bancorp IN reduced its position in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 3.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 255,067 shares of the company's stock after selling 9,889 shares during the quarter. OLD National Bancorp IN's holdings in Roche were worth $8,989,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bard Financial Services Inc. lifted its position in Roche by 37.7% in the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company's stock worth $3,866,000 after purchasing an additional 30,350 shares during the period. GAMMA Investing LLC lifted its position in Roche by 57.7% in the third quarter. GAMMA Investing LLC now owns 7,944 shares of the company's stock worth $317,000 after purchasing an additional 2,906 shares during the period. Diversified Trust Co lifted its holdings in shares of Roche by 6.4% during the third quarter. Diversified Trust Co now owns 59,742 shares of the company's stock valued at $2,396,000 after acquiring an additional 3,613 shares during the period. Norman Fields Gottscho Capital Management LLC lifted its holdings in shares of Roche by 5.5% during the third quarter. Norman Fields Gottscho Capital Management LLC now owns 26,000 shares of the company's stock valued at $1,039,000 after acquiring an additional 1,350 shares during the period. Finally, Canopy Partners LLC lifted its holdings in shares of Roche by 4.6% during the third quarter. Canopy Partners LLC now owns 7,772 shares of the company's stock valued at $310,000 after acquiring an additional 344 shares during the period.
Roche Stock Performance
Shares of OTCMKTS RHHBY traded down $0.59 during midday trading on Friday, reaching $39.25. 1,178,171 shares of the company traded hands, compared to its average volume of 1,942,889. The stock's 50-day simple moving average is $36.14 and its 200-day simple moving average is $38.25. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $42.43. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86.
Roche Profile
(
Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Recommended Stories
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
